We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Revolution Medicines
RVMD
$44B
| $4.03M | ﹤0.01% |
145,572
+6,894
| +5% | +$204K |
|
1477
Nabors Industries
NBR
$1.21B
| $4.03M | ﹤0.01% |
32,691
+39
| +0.1% | +$4.53K |
|
1478
Allegiant Air
ALGT
$2.57B
| $4.01M | ﹤0.01% |
52,178
-1,330
| -2% | -$137K |
|
1479
National Vision
EYE
$1.81B
| $4.01M | ﹤0.01% |
247,753
-3,055
| -1% | -$61.1K |
|
|
ACH
1480
Accendra Health
ACH
$214M
| $4.01M | ﹤0.01% |
247,846
+660
| +0.3% | +$11.7K |
|
1481
Armstrong World Industries
AWI
$7.84B
| $4M | ﹤0.01% |
55,496
-408
| -0.7% | -$30.4K |
|
1482
Golar LNG
GLNG
$5.13B
| $3.98M | ﹤0.01% |
164,189
+1,801
| +1% | +$41.5K |
|
1483
Astrana Health
ASTH
$1.77B
| $3.97M | ﹤0.01% |
128,631
+3,565
| +3% | +$123K |
|
1484
Brady Corp
BRC
$4.57B
| $3.96M | ﹤0.01% |
72,186
-20,389
| -22% | -$1.05M |
|
|
SLCA
1485
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.95M | ﹤0.01% |
281,212
-8,468
| -3% | -$111K |
|
1486
Middlesex Water
MSEX
$1.1B
| $3.95M | ﹤0.01% |
59,589
-2,260
| -4% | -$174K |
|
1487
IonQ
IONQ
$16.6B
| $3.93M | ﹤0.01% |
264,320
+22,733
| +9% | +$357K |
|
1488
Cushman & Wakefield Ltd
CWK
$3.25B
| $3.93M | ﹤0.01% |
516,077
-34,574
| -6% | -$313K |
|
1489
iShares MSCI Poland ETF
EPOL
$756M
| $3.92M | ﹤0.01% |
228,970
-29,800
| -12% | -$573K |
|
1490
Shift4
FOUR
$3.26B
| $3.91M | ﹤0.01% |
70,706
+2,380
| +3% | +$145K |
|
1491
Horace Mann Educators
HMN
$2.11B
| $3.91M | ﹤0.01% |
133,169
-688
| -0.5% | -$20K |
|
|
DISH
1492
DELISTED
DISH Network Corp.
DISH
| $3.91M | ﹤0.01% |
667,017
-52,038
| -7% | -$355K |
|
1493
Stewart Information Services
STC
$2.08B
| $3.91M | ﹤0.01% |
89,220
+508
| +0.6% | +$23K |
|
|
AXNX
1494
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.9M | ﹤0.01% |
69,582
+1,026
| +1% | +$57.7K |
|
1495
Rapid7
RPD
$773M
| $3.9M | ﹤0.01% |
85,186
+1,918
| +2% | +$88.5K |
|
1496
National Beverage
FIZZ
$3.01B
| $3.9M | ﹤0.01% |
82,937
+633
| +0.8% | +$31.9K |
|
1497
Lazard
LAZ
$4.31B
| $3.88M | ﹤0.01% |
125,162
-286
| -0.2% | -$9.59K |
|
1498
Acadia Pharmaceuticals
ACAD
$5.03B
| $3.84M | ﹤0.01% |
184,400
+3,624
| +2% | +$98.4K |
|
1499
AZZ Inc
AZZ
$4.54B
| $3.83M | ﹤0.01% |
83,949
-8,910
| -10% | -$408K |
|
1500
CTS Corp
CTS
$1.89B
| $3.82M | ﹤0.01% |
91,524
+126
| +0.1% | +$5.42K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.